Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
Marcello De Angelis, Maria Petracca, Roberta Lanzillo, Vincenzo Brescia Morra, Marcello Moccia
Topics & Concepts
Multiple sclerosisMedicineCladribineCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseDemographicsVaccinationImmune systemPopulationLymphocyteInternal medicineInfectious disease (medical specialty)Environmental healthSociologyDemographyMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research